When the bladder is surgically removed (an operation called radical cystectomy) to treat bladder cancer, surgeons also remove nearby lymph nodes, small glands that are part of the immune system. This ...
In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease ...
FDA grants Priority Review for Padcev plus Keytruda in muscle-invasive bladder cancer, showing improved survival and reduced ...
EV-304 showed a 47% reduction in recurrence/progression/death versus gemcitabine/cisplatin (EFS HR 0.53; 95% CI 0.41–0.70; one-sided P<.0001). Overall survival improved with perioperative EV plus ...
(Toronto, March 11, 2026) Researchers at Fondazione Policlinico Universitario Agostino Gemelli IRCCS have developed a promising machine learning algorithm capable of predicting survival and cause of ...
Cancer rates in Canada will remain high in 2026. Lung, breast, prostate, and colorectal cancers will be the most common, making up 47% of new diagnoses, according to research published in CMAJ (Canadi ...
Pfizer (NYSE:PFE) received U.S. FDA Priority Review for a supplemental Biologics License Application covering PADCEV plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results